The burden of serious fungal infections in Azerbaijan.

Background: Azerbaijan is an upper middle-income country in South Caucasus with an area of 86,600 km and a total population of 10 million people and gross domestic product of US $4480 per capita. The aim of this research is to estimate fungal infection burden and highlight the problem at national and international levels.

Methods: Fungal infection burden was estimated using data from epidemiological papers and population at risk and LIFE (Leading International Fungal Education) modelling.

The antiseptic Miramistin: a review of its comparative in vitro and clinical activity.

Miramistin is a topical antiseptic with broad antimicrobial action, including activity against biofilms and a clinical profile showing good tolerability. Miramistin was developed within a framework of the Soviet Union Cold War Space Program. It is available for clinical use in several prior Soviet bloc countries, but barely known outside of these countries and there is almost no mention of miramistin in the English literature.

The Burden of Serious Fungal Infections in Kyrgyzstan.

Kyrgyzstan in Central Asia has a population of 6 million people who have high mortality rates for chronic lung diseases. The mountainous geography, widespread use of biomass fuels for cooking and indoor heating, and high rates of smoking are the major contributing factors. We have estimated the number of serious fungal infections in order to define the burden of these diseases in Kyrgyzstan.

The Burden of Serious Fungal Infections in Tajikistan.

Tajikistan is a low-income country in Middle Asia with a population of 8.9 million people. Five percent of the population lives on less than 1.

In vitro and in vivo efficacy of miramistin against drug-resistant fungi.

Introduction: Miramistin is a topical antiseptic with broad antimicrobial activity that was developed in the Soviet Union during the Cold War.

Aim: To investigate the antifungal activity of miramistin against clinically relevant drug-resistant fungi.

Methodology: The in vitro activity of miramistin was determined following Clinical and Laboratory Standards Institute (CLSI) guidelines.

Burden of serious fungal infections in Ukraine.

Ukraine has high rates of TB, AIDS and cancer. We estimated the burden of fungal disease from epidemiology papers and specific populations at risk and fungal infection frequencies. HIV/AIDS cases and deaths (2012) and tuberculosis statistics were obtained from the State Service of Ukraine, while chronic obstructive pulmonary disease (COPD) cases were from M.